TherapeuticsMD Inc. (TXMD)
1.05
0.06 (6.08%)
At close: Apr 14, 2025, 3:56 PM
0.94
-10.18%
After-hours: Apr 14, 2025, 07:56 PM EDT
6.08% (1D)
| Bid | 0.92 |
| Market Cap | 12.15M |
| Revenue (ttm) | 1.76M |
| Net Income (ttm) | -2.18M |
| EPS (ttm) | -0.2 |
| PE Ratio (ttm) | -5.25 |
| Forward PE | 3.06 |
| Analyst | n/a |
| Ask | 0.94 |
| Volume | 27,863 |
| Avg. Volume (20D) | 300,329 |
| Open | 1.01 |
| Previous Close | 0.99 |
| Day's Range | 0.98 - 1.06 |
| 52-Week Range | 0.70 - 2.44 |
| Beta | 0.95 |
About TXMD
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone...
Sector Healthcare
IPO Date May 9, 2007
Employees 1
Stock Exchange NASDAQ
Ticker Symbol TXMD
Website https://www.therapeuticsmd.com
